Mayo Researchers Change NCCN Criteria to Expand Genetic Testing in Breast Cancer

Mayo Researchers: Change NCCN Criteria to Expand Genetic Testing in Breast Cancer

Researchers at the Mayo Clinic maintain that all women aged 65 or under with a breast cancer diagnosis should receive germline genetic testing to identify harmful mutations that increase their risk of developing secondary cancers.

More From BioPortfolio on "Mayo Researchers: Change NCCN Criteria to Expand Genetic Testing in Breast Cancer"